- All sections
- A - Human necessities
- A61P - Specific therapeutic activity of chemical compounds or medicinal preparations
- A61P 5/18 - Drugs for disorders of the endocrine system of the parathyroid hormones
Patent holdings for IPC class A61P 5/18
Total number of patents in this class: 150
10-year publication summary
|
5
|
6
|
12
|
9
|
6
|
8
|
7
|
8
|
13
|
1
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Ascendis Pharma Bone Diseases A/S | 49 |
21 |
| Daiichi Sankyo Company, Limited | 1875 |
8 |
| Entera Bio Ltd. | 47 |
7 |
| Amgen Inc. | 4301 |
6 |
| Asahi Kasei Pharma Corporation | 119 |
5 |
| Wisconsin Alumni Research Foundation | 3918 |
4 |
| Takeda Pharmaceutical Company Limited | 2713 |
4 |
| EA Pharma Co., Ltd. | 91 |
4 |
| EirGen Pharma Limited | 88 |
4 |
| Xeris Pharmaceuticals, Inc. | 108 |
4 |
| LEO Pharma A/S | 461 |
4 |
| Vertex Pharmaceuticals Incorporated | 1617 |
3 |
| Chugai Seiyaku Kabushiki Kaisha | 1386 |
3 |
| Kyowa Hakko Kirin Co., Ltd. | 279 |
3 |
| Lupin Limited | 434 |
3 |
| Mironid Limited | 23 |
3 |
| The General Hospital Corporation | 4798 |
2 |
| Ajinomoto Co., Inc. | 2300 |
2 |
| Dainippon Sumitomo Pharma Co., Ltd. | 176 |
2 |
| Dongguk University Industry-Academic Cooperation Foundation | 457 |
2 |
| Other owners | 56 |